Majority of Landmark Cancer Studies Cannot Be Replicated

Majority of Landmark Cancer Studies Cannot Be Replicated

April 6th, 2012

Mmm hmm.

Via: Slashdot:

“During a decade as head of global cancer research at Amgen, C. Glenn Begley identified 53 ‘landmark’ publications — papers in top journals, from reputable labs — for his team to reproduce. Begley sought to double-check the findings before trying to build on them for drug development. Result: 47 of the 53 could not be replicated. He described his findings in a commentary piece published on Wednesday in the journal Nature (paywalled) . … But they and others fear the phenomenon is the product of a skewed system of incentives that has academics cutting corners to further their careers.”

Related: American Society for Microbiology: ‘Has Modern Science Become Dysfunctional?’

<!– AD CAN GO HERE

Buy gold online - quickly, safely and at low prices

END: AD CAN GO HERE –>

Leave a Reply

You must be logged in to post a comment.

You can skip to the end and leave a response. Pinging is currently not allowed.

Leave a Reply

Powered by WordPress | Designed by: Premium WordPress Themes | Thanks to Themes Gallery, Bromoney and Wordpress Themes